Eli Lilly and Company

Graham Barry Jones

Christopher Kovalchick

Christopher John Demaria

Sean Matthew Pszenny

Daniel Morris Hartmann

Monica Rixman Swinney

Rhea Sirkar

An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.

Growing community of inventors

South Easton, MA, United States of America

Graham Barry Jones